Gastric cancer: Epidemiology, risk factors and significance of nutrition;Magenkarzinom: Epidemiologie, risikofaktoren und rolle der ernahrung

Chirurgische Gastroenterologie mit Interdisziplinaren Gesprachen

Volumn 15, Issue 3, 1999, Pages 211-214

  Puspok A ^b   Ferenci, P ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Antioxidants; Carcinogens; Gastric cancer; Helicobacter pylori

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CARCINOGEN;

ARTICLE; ATROPHIC GASTRITIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; FOOD PROCESSING; GARLIC; GASTRECTOMY; HELICOBACTER PYLORI; HUMAN; NUTRITION; PERNICIOUS ANEMIA; RISK FACTOR; STOMACH CANCER; STOMACH MUCOSA; TEA;

EID: 2442749668     PISSN: 01779990     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012559     Document Type: Article

References (37)

1. Coolman MP, Esteve J, Damiecki P, Arslan A, Renard H: Trends in cancer incidence and mortality. IARC Sci Publ 1993;121:1-806.
2. Devesa SS, Blot WJ, Fraumeni JF Jr: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-2053.
3. Lagergren J, Bergstrom R, Lindgren A, Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-831.
4. .Laurén P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:31-49.
5. Haenszel W, Kurihara M, Locke FB, Shimuzu K, Segi M: Stomach cancer in Japan. J Natl Cancer Inst 1976;56:265-274.
6. Correa P: Human gastric carcinogenesis: A multistep and multifactorial progress. 1st American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-6740.
7. Tatsuta M, Yamamura H, Taniguchi H, Tamura H: Gastrin protection against chemically induced gastric adenocarcinomas in Wistar rats: Histopathology of the glandular stomach and incidence of gastric adenocarcinoma. J Natl Cancer Inst 1982;69:59-66.
8. Stalnikowicz R, Benbassat J: Risk of gastric cancer after gastric surgery for benign disorders. Arch Intern Med 1990;150:2022-2026.
9. Tersmette AC, Offerhaus GJ, Tersmette KW, Giardiello FM, Moore GW, Tytgat GN, Vandenbroucke JP: Meta-analysis of the risk of gastric stump cancer: Detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions. Cancer Res 1990;50:6486-6489.
10. Blackburn E, Callender S, Dacie J, et al: Possible association between pernicious anemia and leukemia: a prospective study of 1,625 patients with a note on the very high incidence of stomach cancer. Int J Cancer 1968;3:163-170.
11. Brinton LA, Gridley G, Hrubec Z, Hoover R, Fraumeni JF, Jr. Cancer risk following pernicious anaemia. Br J Cancer 1989;59:810-813.
12. Hsing AW, Hansson LE, McLaughlin JK, Nyren O, Blot WJ, Ekbom A, Fraumeni JF Jr: Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 1993;71: 745-750.
13. Harvey RF, Bradshaw MJ, Davidson CM, Wilkinson SP, Davies PS. Multifocal gastric carcinoid tumours, achlorhydria, and hypergastrinaemia. Lancet 1985;i:951-954.
14. Nakamura T, Nakano G: Histopathological classification and malignant change in gastric polyps. J Clin Pathol 1985;38:754-764.
15. Ménétrier P: Des polyadénomas gastriques et de leurs rapports avec le cancer de l'estomac. Arch Physiol Norm Pathol 1888;1:322-336.
16. Matzner M, Raab A, Spear P: Benign giant gastric rugae complicated by submucosal gastric carcinoma: Report of a case. Gastroenterology 1951;18:296-302.
17. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Schistosomes, liver flukes and Helicobacter pylori. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
18. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, Sitas F: Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. BMJ 1991;302:1302-1305.
19. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez Perez GI, Blaser MJ: Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-1136.
20. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131.
21. Tsujii M, Kawano S, Tsuji S, Nagano K, Ito T, Hayashi N, Fusamoto H, Kamada T, Tamura K: Ammonia: A possible promoter in Helicobacter pylori-related gastric carcinogenesis. Cancer Lett 1992;65:15-18.
22. Sidebotham RL, Batten JJ, Karim QN, Spencer J, Baron JH: Breakdown of gastric mucus in presence of Helicobacter pylori. J Clin Pathol 1991;44:52-57.
23. Davies GR, Simmonds NJ, Stevens TR, Sheaff MT, Banatvala N, Laurenson IF, Blake DR, Rampton DS: Helicobacter pylori-stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994;35:179-185.
24. Ruiz B, Rood JC, Fontham ET, Malcom GT, Hunter FM, Sobhan M, Johnson WD, Correa P: Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am J Gastroenterol 1994;89:533-539.
25. Lynch DA, Mapstone NP, Clarke AM, Sobala GM, Jackson P, Morrison L, Dixon MF, Quirke P, Axon AT: Cell proliferation in Helicobacter pylori-associated gastritis and the effect of eradication therapy. Gut 1995;36:346-350.
26. Witherell HL, Hiatt RA, Replogle M, Parsonnet J: Helicobacter pylori infection and urinary excretion of 8-hydroxy-2-deoxyguanosine, an oxidative DNA adduct. Cancer Epidemiol Biomarkers Prev 1998;7:91-96.
27. Holcombe C: Helicobacter pylori: The African enigma. Gut 1992;33:429-431.
28. Blaser MJ, Perez Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A: Infections with Heliobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-2115.
29. Parsonnet J, Friedman GD, Orentreich N, Vogelman H: Risk for gastric cancer in people with CagA positive or CagA negative Heliobacter pylori infection [see comments]. Gut 1997;40(3): 297-301.
30. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Munakata A, Crabtree JE: CagA seropositivity associated with development of gastric cancer in a Japanese population. J Clin Pathol 1998;51: 225-228.
31. Torres J, Perez Perez GI, Leal Herrera Y, Munoz O: Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico. Int J Cancer 1998;78:298-300.
32. Webb PM, Crabtree JE, Forman D: Gastric cancer, cytotoxin-associated gene A-positive Heliobacter pylori, and serum pepsinogens: An international study. The Eurogast Study Group. Gastroenterology 1999;116:269-276.
33. Haenszel W, Kurihara M, Segi M, Lee RK: Stomach cancer among Japanese in Hawaii. J Natl Cancer Inst 1972;49:969-988.
34. Ruiz B, Correa P, Fontham ET, Rood JC, Malcom GT, Torrado J, Perez A, Ramakrishnan T, Hunter FM: Ascorbic acid, Helicobacter pylori and Lewis phenotype among blacks and whites in New Orleans. Cancer Lett 1994;83:323-329.
35. Ji BT, Chow WH, Yang G, McLaughlin JK, Gao RN, Zheng W, Shu XO, Jin F, Fraumeni JF Jr, Gao YT: The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Cancer 1996;77:2449-2457.
36. Dorant E, van den Brandt PA, Goldbohm RA, Hermus RJ, Sturmans F: Garlic and its significance for the prevention of cancer in humans: A critical view. Br J Cancer 1993;67:424-429.
37. Lee-Anderson PH, Goel A, Boland CR, Chauhan DP: Green tea polyphenols: New agents for human colorectal cancer prevention. Gastroenterology 1999;116(suppl 1):1619A.